Agenda for Pre-Conference Workshops – Monday, March 22, 2027 - EST/EDT (Eastern Daylight, GMT-4)
Attendees Choose Between 3 Pre-Conference Add-On Workshops (A-C)
Analyze the status of MFN policy proposals and their potential implementation timeline
Examine the GLOBE Model (Global Benchmark for Efficient Drug Pricing) and its impact on Medicare Part B drug pricing
Analyze the GUARD Model and its implications for patient access and rare disease therapies
Compare and contrast MFN, GLOBE, and GUARD approaches, including key differences, overlap and combined impact on the market
Address strategies to maintain patient access amid evolving international pricing benchmarks
Examine the five-year performance period implications for long-term patient support planning
- Max Bronstein - Founder, CEO, Aviva Strategies
- Navigate the sweeping changes from the One Big Beautiful Bill Act affecting Medicaid and Medicare
- Master strategies for serving dual-eligible populations amid increased redetermination frequency and eligibility restrictions
- Address the impact of retroactive coverage limitations on patient enrollment and support
- Explore the $35 copay per service requirement for some Medicaid enrollees (effective October 2028) and early preparation strategies
Map specific AI technologies to common patient journey pain points, from enrollment to adherence support
Build a framework for assessing AI maturity and readiness within your organization's patient support infrastructure
Navigate the AI vendor landscape and distinguish between platform providers, point solutions and custom development options
Develop change management strategies that position AI as augmentation rather than replacement
Build a culture where teams feel empowered to experiment, provide feedback and shape AI evolution
Master the current FDA guidance and industry standards governing AI applications in patient support programs
Implement ethical frameworks that protect patient data while enabling personalized patient experiences
Create governance structures that maintain human oversight while leveraging AI capabilities
Develop a vendor evaluation framework and master the RFP process for AI solutions, including must-have compliance requirements vs. nice-to-haves
Understand how accumulator adjustment programs, maximizers and alternative funding programs (AFPs) function and why payers and employers are implementing them
Analyze current prevalence data: which therapeutic categories, payers and patient populations are most affected
Examine the legal and regulatory landscape, including recent state legislation, federal policy proposals and potential regulatory remedies
Stay informed on emerging AFP tactics and evolving payer restrictions entering the market
Hear real patient stories illustrating how AFPs disrupt medication access and create financial hardship
Analyze data on therapy abandonment rates, discontinuation and out-of-pocket burden caused by cost-sharing programs
Map the patient journey to identify critical moments where AFPs create confusion and access barriers
Identify early warning signs that a patient may be affected by an AFP before access disruption occurs
Examine the second wave of Medicare drug price negotiations and their impact on patient assistance program design
Understand how the increased $2,400 out-of-pocket cap affects patient affordability and program eligibility
Navigate the evolving landscape of negotiated Maximum Fair Prices (MFPs) and their implications for patient support services
Adapt copay assistance and patient support programs to align with Part D benefit restructuring
Participate in facilitated roundtable discussions with industry peers navigating the same policy implementation challenges
Share real-world experiences from the first weeks of January 2027 policy rollouts – what's working, what's failing and what surprised your organization
Crowdsource strategies for addressing dual-eligible patient disruptions, IRA negotiation impacts and preparing for international reference pricing implementation
Develop action items and cross-policy mitigation plans based on peer insights and workshop learnings
Analyze case studies of AI implementations that significantly improved common paint points, such as prior authorization success rates and adherence metrics
Work in small groups to test AI solutions with scenarios from your own operations
Evaluate integration approaches that connect AI capabilities with existing hub service platforms and workflows
Define success metrics that go beyond efficiency gains to measure patient impact and quality outcomes
Build a business case framework that quantifies both hard savings (FTE reduction, faster processing) and soft benefits (patient satisfaction, staff retention)
Develop a phased implementation plan with clear milestones, success metrics, and resource requirements
Create your personalized 90-day action plan and leave with a stakeholder engagement strategy to secure buy-in from leadership, IT, compliance and frontline teams
- Participate in facilitated roundtable discussions with industry peers facing similar challenges
- Share real-world case studies, lessons learned and innovative solutions that have successfully protected patient access
- Crowdsource strategies for emerging AFP tactics and payer restrictions that are just beginning to appear in the market
- Develop action items and next steps based on peer insights and workshop learnings
